| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/02/2009 | EP2094695A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 09/02/2009 | EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094682A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 09/02/2009 | EP2094681A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 09/02/2009 | EP2094671A1 Heterobicyclic metalloprotease inhibitors |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094266A1 Crth2 antagonists |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1784405A4 Determination of nucleic acid using electrocatalytic intercalators |
| 09/02/2009 | EP1771440A4 Generic probes for the detection of phosphorylated sequences |
| 09/02/2009 | EP1651648A4 Compounds and compositions as protein kinase inhibitors |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | CN101522679A Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors |
| 09/02/2009 | CN101522678A New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 09/02/2009 | CN101522677A Fungicidal n-heteroaryl-condensed pyridine derivatives and fungicidal compositions |
| 09/02/2009 | CN101522676A Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl CoA desaturase inhibitors |
| 09/02/2009 | CN101522675A 2-amido-4-isoxazolyl thiazole compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519372A Benzo [e] isoindazole-1,3 diketone compound used as GSK inhibiting agent and preparation method thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/01/2009 | US7582761 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582758 producing cyclic phosphonic acid diesters prodrugs, used to improve the oral bioavailability; by reacting a chiral 1,3-diol and an activated phosphonic acid in the presence of a Lewis acid; Adefovir drug target delivery to liver |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582652 Kinase inhibitors |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582649 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 09/01/2009 | CA2396209C The use of mirtazapine for the treatment of sleep disorders |
| 08/27/2009 | WO2009105717A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105435A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/27/2009 | WO2009103966A1 Bicyclylaryl-aryl-amine compounds and their use |
| 08/27/2009 | WO2009103879A1 Novel nitrogen-containing organic compounds that can be used as precursor of a catalytic composition |
| 08/27/2009 | WO2009103787A1 Process for the preparation of 2,3,4,9-tetrahydro-1h-beta-carbolin-3-carboxylic acid esters" |
| 08/27/2009 | WO2009103478A1 Pyridone and pyridazinone derivatives as mch antagonists |
| 08/27/2009 | US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215818 Thiozolidinedione derivatives as pi3 kinase inhibitors |
| 08/27/2009 | US20090215817 Novel Triazolopyridine Compounds for the Treatment of Inflammation |
| 08/27/2009 | US20090215816 Imidazo(1,2-a)Pyridine Derivatives Useful as Peptide Deformylase (PDF) Inhibitors |
| 08/27/2009 | US20090215815 Neurotrophin antagonist compositions |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215799 Heterocyclic substituted bisarylurea derivatives |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215784 Maleate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 08/27/2009 | US20090215783 Composition for induction or inhibition of stem cell differentiation |
| 08/27/2009 | US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/27/2009 | US20090212280 Use of a Metal Complex as an N-Dopant for an Organic Semiconducting Matrix Material, Organic of Semiconducting Material and Electronic Component, and also a Dopant and Ligand and Process for Producing same |
| 08/27/2009 | CA2716349A1 Methods for inhibiting drug degradation |
| 08/27/2009 | CA2716330A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2715872A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | CA2715557A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | CA2714700A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/27/2009 | CA2713182A1 Azatricyclic antibiotic compounds |
| 08/26/2009 | EP2093227A1 Polynuclear complex |
| 08/26/2009 | EP2093226A1 New aminoindolizines, tinctorial composition comprising an aminoindolizine, methods and uses |
| 08/26/2009 | EP2092794A1 Phenanthroline compounds and electroluminescent devices using the same |
| 08/26/2009 | EP2091951A2 Pyrido[2,3-b]pyrazine and[1,8]-naphtyridine derivatives as alk and c-met inhibitors |
| 08/26/2009 | EP2091943A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP2091536A2 Enantiomeric compounds with antibacterial activity |
| 08/26/2009 | EP2007764B1 Process for the preparation of cgrp antagonist |
| 08/26/2009 | EP1791539B1 Process to prepare camptothecin derivatives |
| 08/26/2009 | EP1773817B1 Substituted aryl-amine derivatives and methods of use |
| 08/26/2009 | EP1745033A4 4,5-disubstituted-2-aryl pyrimidines |
| 08/26/2009 | EP1694676B1 Spiroindoline derivatives having insecticidal properties |
| 08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 08/26/2009 | EP1603910B1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | CN101516881A 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 08/26/2009 | CN101516880A Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine |
| 08/26/2009 | CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 08/26/2009 | CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 08/26/2009 | CN101514201A Preparation method for (4,7-cis)-octahydro-pyrrolo[3,4-b]pyridine and moxifolxacin |
| 08/26/2009 | CN101513405A Use of chemotherapeutic agents |
| 08/25/2009 | US7579470 3-(4-Chloro-phenyl)-2-methyl-2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene; serotonin receptor modulator; anxiolytic, antidepressant, antiinflammatory agent, analgesic; psychological, sleep, eating, bipolar, sexual disorders; schizophrenia, obesity, retinopathy |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579359 imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines; immunomodulators for inducing cytokine biosynthesis; for treatment of viral and neoplastic diseases |
| 08/25/2009 | US7579356 Thia-tetraazaacenaphthylene kinase inhibitors |
| 08/25/2009 | US7579349 anticarcinogenic agent 5-Chloro-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; chemical synthesis; use in modulating insulin-like growth factor 1 receptor activity |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |